- Home
- IGT vs BHVN Comparison
IGT vs BHVN Comparison
Compare IGT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGT
- BHVN
- Stock Information
- Founded
- IGT 2014
- BHVN 2013
- Country
- IGT United Kingdom
- BHVN United States
- Employees
- IGT N/A
- BHVN N/A
- Industry
- IGT Services-Misc. Amusement & Recreation
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- IGT Consumer Discretionary
- BHVN Health Care
- Exchange
- IGT Nasdaq
- BHVN Nasdaq
- Market Cap
- IGT 4.1B
- BHVN 3.6B
- IPO Year
- IGT N/A
- BHVN 2017
- Fundamental
- Price
- IGT $17.24
- BHVN $36.17
- Analyst Decision
- IGT Buy
- BHVN Strong Buy
- Analyst Count
- IGT 6
- BHVN 13
- Target Price
- IGT $28.67
- BHVN $63.00
- AVG Volume (30 Days)
- IGT 960.3K
- BHVN 1.1M
- Earning Date
- IGT 11-12-2024
- BHVN 11-12-2024
- Dividend Yield
- IGT 4.65%
- BHVN N/A
- EPS Growth
- IGT 33.70
- BHVN N/A
- EPS
- IGT 0.68
- BHVN N/A
- Revenue
- IGT $4,320,000,000.00
- BHVN N/A
- Revenue This Year
- IGT N/A
- BHVN N/A
- Revenue Next Year
- IGT $2.27
- BHVN $197.10
- P/E Ratio
- IGT $27.44
- BHVN N/A
- Revenue Growth
- IGT 46.94
- BHVN N/A
- 52 Week Low
- IGT $16.96
- BHVN $26.80
- 52 Week High
- IGT $27.89
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- IGT 23.43
- BHVN 33.02
- Support Level
- IGT $16.97
- BHVN $36.70
- Resistance Level
- IGT $18.21
- BHVN $42.13
- Average True Range (ATR)
- IGT 0.45
- BHVN 2.84
- MACD
- IGT -0.21
- BHVN -0.67
- Stochastic Oscillator
- IGT 5.00
- BHVN 13.18
About IGT International Game Technology
International Game Technology PLC is a gaming company that delivers entertaining and responsible gaming experiences for players across all channels. The company's operating segments include Global Lottery, Global Gaming, and PlayDigital. It generates maximum revenue from the Global Lottery segment. Global Lottery segment provides lottery products and services to governmental organizations through operating contracts, facilities management contracts, lottery management agreements, and product sales contracts. Geographically, it derives a majority of revenue from the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.